product summary
request information :
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
Mouse Monoclonal Insulin R/CD220 Antibody
catalog :
NB400-142
quantity :
0.1 ml
price :
329 USD
clonality :
monoclonal
host :
mouse
reactivity :
mouse, rat, human
application :
immunoprecipitation, ELISA, neutralization, western blot
publications citing this reagent :
  1. mouse (ELISA)
    Morcavallo A, Buraschi S, Xu S, Belfiore A, Schaefer L, Iozzo R, et al. Decorin differentially modulates the activity of insulin receptor isoform A ligands. Matrix Biol. 2014;35:82-90 pubmed publisher
more info or order :
product information
Catalog Number :
NB400-142
Product Name :
Mouse Monoclonal Insulin R/CD220 Antibody
List Price :
329 USD
Product Type :
Primary Antibodies
Package Size :
0.1 ml
AltNames :
CD 220, CD220, CD220 antigen, EC 2.7.10, EC 2.7.10.1, HHF5, insulin receptor, IR
Buffer :
10 mM phosphate buffer [pH 7.4], 100 mM NaCl.
Clonality :
Monoclonal
Clone :
MA-20
Concentration :
1.2 mg/ml
Application Summary :
Western Blot, Blocking/Neutralizing, ELISA, Immunoprecipitation
Host :
Mouse
Immunogen :
Highly purified Insulin Receptor (alpha-subunit) from human term placentas. [UniProt# P06213]
Isotype :
IgG2b
Localization :
Membrane; single pass type I membrane protein.
Preservative :
0.1% Sodium Azide
Purity :
Protein G purified
CrossReactivity :
Human and rat. Mouse reactivity reported in scientific literature (PMID: 24389353)
Storage :
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Swissprot Human :
P06213
Uses :
This Insulin Receptor (MA-20) antibody is useful for ELISA, Immunoprecipitation, Western blot and Blocking/Neutralizing assays.
Research Area :
Diabetes Research, Lipid and Metabolism, Neuroscience, Nutrient Sensing in the Brain, Protein Kinase, Signal Transduction, Tyrosine Kinases
References Product :
Morcavallo A, Buraschi S, Xu SQ et al. Decorin differentially modulates the activity of insulin receptor isoform A ligands. Matrix Biol 2014 Jan 2 [PMID: 24389353] (ELISA, Mouse) Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V, Belfiore A. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab;87(1):245-54. 2002 Jan. [PMID: 11788654] Li, M et al. Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells. Diabetes;50(10):2323-8. 2001 Oct. [PMID: 11574415] (WB, ELISA, Human) Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A, Vigneri R, Frittitta L. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes;50(4):831-6. 2001 Apr. [PMID: 11289049] (ELISA, Human) Maddux BA, Goldfine ID. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes;49(1):13-9. 2000 Jan. [PMID: 10615944] Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID, Belfiore A. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res;5(7):1935-44. 1999 Jul. [PMID: 10430101] Frasca, F et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol;19(5):3278-88. 1999 May. [PMID: 10207053] (IP, ELISA, Human) Forsayeth JR, Caro JF, Sinha MK, Maddux BA, Goldfine ID. Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. Proc Natl Acad Sci U S A;84(10):3448-51. 1987 May. [PMID: 3033648] (IP, B/N, Human) Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem;277(42):39684-95. 2002 Oct 18. [PMID: 12138094] (WB, IP, ELISA , Human) Federici, M et al. Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. J Clin Invest;98(12):2887-93. 1996 Dec 15. [PMID: 8981937] (WB, Human) Gherzi R, Russell DS, Taylor SI, Rosen OM. Reevaluation of the evidence that an antibody to the insulin receptor is insulinmimetic without activating the protein tyrosine kinase activity of the receptor. J Biol Chem;262(35):16900-5. 1987 Dec 15. [PMID: 3680277] Hawley DM, Maddux BA, Patel RG, Wong KY, Mamula PW, Firestone GL, Brunetti A, Verspohl E, Goldfine ID. Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase. J Biol Chem;264(5):2438-44. 1989 Feb 15. [PMID: 2536710] Forsayeth, JR et al. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J Biol Chem;262(9):4134-40. 1987 Mar 25. [PMID: 2435731] (B/N, Human) Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID, Belfiore A. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res;52(14):3924-30. 1992 Jul 15. [PMID: 1617668]
more info or order :
company information
Novus Biologicals
8100 Southpark Way, A-8
Littleton, CO 80120
novus@novusbio.com
www.novusbio.com
3037301950
headquarters: USA
The mission of Novus Biologicals, LLC is to accelerate scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological research community with a mechanism for commercializing unique biological materials. We also focus on continually monitoring scientific trends and supply materials to serve these trends. By making these products widely available to institutional and commercial researchers, Novus Biologicals plays an important role in furthering biological research. All of Novus Biologicals products are supplied with detailed technical information and ongoing support. By serving niche and emerging markets, Novus Biologicals has become specialists in markets and has formed and will continue to form ongoing partnerships with our customers.